Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             165 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case of Addison's disease complicated by lung carcinoma treated with surgical resection - A case report 1996
14 2-3 p. 391-
1 p.
artikel
2 Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis 1996
14 2-3 p. 385-
1 p.
artikel
3 Adding a reverser (verapamil) to combined chemotherapy overrides resistance in small cell lung cancer xenografts 1996
14 2-3 p. 399-400
2 p.
artikel
4 Adjuvant chemo-immunotherapy after curative resection of Stage II and IIIA primary lung cancer Kimura, Hideki
1996
14 2-3 p. 301-314
14 p.
artikel
5 Alterations of CDKN2 (p16) in non-small cell lung cancer 1996
14 2-3 p. 382-
1 p.
artikel
6 Analytical performances of Cyfra 21 and CEA assays with an ES 300 Boehringer. Interest for the diagnosis and the followup patients suffering from NSC bronchial cancer 1996
14 2-3 p. 390-
1 p.
artikel
7 An ecological study of diet and lung cancer in the South Pacific 1996
14 2-3 p. 380-
1 p.
artikel
8 Antitumor activity of treosulfan in human lung carcinomas 1996
14 2-3 p. 403-
1 p.
artikel
9 A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer: A University of Colorado Cancer Center Study 1996
14 2-3 p. 400-
1 p.
artikel
10 A randomized Phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: A Cancer and Leukemia Group B study Graziano, Stephen L.
1996
14 2-3 p. 315-329
15 p.
artikel
11 A rare case of primary pulmonary choriocarcinoma in a male: Immunohistochemical detection for human chorionic gonadotropin, epidermal growth factor (EGF) and EGF-receptor 1996
14 2-3 p. 384-
1 p.
artikel
12 Assessment of quality of life by clinicians — Experience of a practical method in lung cancer patients 1996
14 2-3 p. 394-
1 p.
artikel
13 A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue 1996
14 2-3 p. 381-
1 p.
artikel
14 Blood and lymphatic vessel invasion as prognostic factors for patients with primary resected nonsmall cell carcinoma of the lung with intrapulmonary metastases 1996
14 2-3 p. 387-388
2 p.
artikel
15 Brain metastases from lung and breast cancer. Differences in patterns of spread and prognosis 1996
14 2-3 p. 388-
1 p.
artikel
16 Bronchioloalveolar carcinoma and congenital cystic adenomatoid malformation 1996
14 2-3 p. 394-
1 p.
artikel
17 Bylaws of the International Association for the Study of Lung Cancer 1996
14 2-3 p. 361-365
5 p.
artikel
18 Calendar 1996
14 2-3 p. 375-376
2 p.
artikel
19 Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity Matsubara, Shuji
1996
14 2-3 p. 265-271
7 p.
artikel
20 CEA, CYFRA21-1 and SCC in non-small cell lung cancer 1996
14 2-3 p. 395-
1 p.
artikel
21 Chemotherapy in advanced non-small-cell lung cancer. The experience of Italian Cooperative Groups 1996
14 2-3 p. 399-
1 p.
artikel
22 Chemotherapy of stage IIIB and IV non-small-cell lung cancer 1996
14 2-3 p. 405-
1 p.
artikel
23 Clinical Characteristics of synchronous multiple lung cancer associated with idiopathic pulmonary fibrosis: A review of Japanese cases 1996
14 2-3 p. 393-
1 p.
artikel
24 Clinical significance or argyrophilic nucleolar organizer regions (AgNORs) in squamous cell carcinoma of the lung 1996
14 2-3 p. 385-
1 p.
artikel
25 Combination chemoimmunotherapy with interferon-alpha and cisplatin in patients with advanced non-small cell lung cancer 1996
14 2-3 p. 397-398
2 p.
artikel
26 Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer 1996
14 2-3 p. 388-
1 p.
artikel
27 Comparison of single vs combined modality treatment in locally advanced non-small cell lung cancer 1996
14 2-3 p. 407-
1 p.
artikel
28 Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung 1996
14 2-3 p. 378-379
2 p.
artikel
29 Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases 1996
14 2-3 p. 393-394
2 p.
artikel
30 CYP2D6 genotype and lung cancer risk according to histologic type and tobacco exposure 1996
14 2-3 p. 378-
1 p.
artikel
31 Cytostatic chemotherapy for small cell lung cancer in patients of age 75 years or older 1996
14 2-3 p. 401-
1 p.
artikel
32 Dealing with initial chemotherapy doses: A new basis for treatment optimisation in limited small-cell lung cancer 1996
14 2-3 p. 405-
1 p.
artikel
33 Descriptive epidemiological study on lung cancer 1996
14 2-3 p. 378-
1 p.
artikel
34 Diagnosis and staging of bronchogenic carcinoma by transtracheal and transbronchial needle aspiration 1996
14 2-3 p. 389-
1 p.
artikel
35 Diagnostic usefulness of five tumor markers in patients with primary lung cancer 1996
14 2-3 p. 394-395
2 p.
artikel
36 Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France 1996
14 2-3 p. 408-
1 p.
artikel
37 Differential diagnosis of thymic carcinoma and lung carcinoma with the use of antibodies to cytokeratins 1996
14 2-3 p. 383-384
2 p.
artikel
38 Disease monitoring by the tumour maskers Cyfra 21.1 and TPA in patients with non-small cell lung cancer 1996
14 2-3 p. 392-
1 p.
artikel
39 Distinct mutational spectrum of the p53 gene in lung cancers from Chinese women in Hong Kong 1996
14 2-3 p. 378-
1 p.
artikel
40 Effect of human recombinant interferon-α on the activity of cis-diamminedichloroplatinum(II) in human non-small cell lung cancer xenografts 1996
14 2-3 p. 398-
1 p.
artikel
41 Effect of recombinant human G-CSF (rhG-CSF) in patients with non-small, cell lung cancer (NSCLC) treated with combination chemotherapy of cisplatin, ifosfamide, and indesine (CIV chemotherapy) 1996
14 2-3 p. 402-
1 p.
artikel
42 Endoluminal HDR brachytherapy as a palliative treatment of patients with recurrent previously irradiated non-small cell lung carcinoma 1996
14 2-3 p. 404-
1 p.
artikel
43 Endoscopical and morphological characterization of lung cancer 1996
14 2-3 p. 389-
1 p.
artikel
44 Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma 1996
14 2-3 p. 392-
1 p.
artikel
45 Epigenetic regulation of multidrug resistance and metastasis-related genes in human lung adenocarcinoma cells growing in ectopic or orthotopic organs of nude mice 1996
14 2-3 p. 399-
1 p.
artikel
46 Evaluation and prognostic value of DNA content and of morphometric parameters in malignant mesothelioma using digital image analysis Segers, Kurt
1996
14 2-3 p. 229-237
9 p.
artikel
47 Evaluation of cases with combined bronchoplasty and pulmonary arterioplasty for the treatment of lung cancer 1996
14 2-3 p. 397-
1 p.
artikel
48 Evaluation of proliferation parameters in in vivo bromodeoxyuridine labelled lung cancers 1996
14 2-3 p. 382-
1 p.
artikel
49 Evaluation of rG-CSF subcutaneous administration in two separate doses in chemotherapy for primary lung cancer patients 1996
14 2-3 p. 401-402
2 p.
artikel
50 Evaluation of solitary pulmonary nodules with dynamic contrast-enhanced MR imaging - A promising technique? 1996
14 2-3 p. 393-
1 p.
artikel
51 Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus 1996
14 2-3 p. 382-383
2 p.
artikel
52 Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas 1996
14 2-3 p. 386-
1 p.
artikel
53 Expression of bcl-2 protein in stage T1N0M0 non-small cell lung carcinoma 1996
14 2-3 p. 384-385
2 p.
artikel
54 Expression of transforming growth factor-α and transforming growth factor-β in human primary lung cancer 1996
14 2-3 p. 383-
1 p.
artikel
55 Fusion of immunoscintigraphy single photon emission computed tomography (SPECT) with CT of the chest in patients with non-small cell lung cancer 1996
14 2-3 p. 391-
1 p.
artikel
56 Gemcitabine in the treatment of non-small-cell lung cancer 1996
14 2-3 p. 405-
1 p.
artikel
57 Gene therapy for lung cancer 1996
14 2-3 p. 408-
1 p.
artikel
58 Genetic analysis by fluorescence in situ hybridization of lung cancer cells obtained by bronchial brushing 1996
14 2-3 p. 392-
1 p.
artikel
59 ICE combination therapy in advanced non-small cell lung cancer 1996
14 2-3 p. 402-
1 p.
artikel
60 Immunoreacitive prostate-specific antigen in lung tumors 1996
14 2-3 p. 382-
1 p.
artikel
61 Increased expression of Bcl-2 in drug-resistant squamous cell lung carcinomas 1996
14 2-3 p. 398-399
2 p.
artikel
62 Induction chemotherapy followed by adjuvant surgery (ICAS) in patients with stage I–II small cell lung cancer (SCLC) 1996
14 2-3 p. 405-
1 p.
artikel
63 Induction or concomitant chemotherapy and radiotherapy for non-small-cell lung cancer: myth or reality 1996
14 2-3 p. 405-406
2 p.
artikel
64 Industries and occupations at increased risk of lung cancer mortality in Turin (1981–1989) and Italy (1981–1982) 1996
14 2-3 p. 379-
1 p.
artikel
65 Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells 1996
14 2-3 p. 394-
1 p.
artikel
66 In situ detection of Epstein-Barr virus in non-small cell lung carcinomas 1996
14 2-3 p. 385-
1 p.
artikel
67 In situ end-labelling, light microscopic assessment and ultrastructure of apoptosis in lung carcinoma 1996
14 2-3 p. 384-
1 p.
artikel
68 Integrin expression in non-small cell carcinoma of the lung 1996
14 2-3 p. 386-
1 p.
artikel
69 Interleukin-1α and soluble interleukin-2 receptor during small cell lung cancer chemotherapy: Comparison of high chemotherapy dose with rhGM-CSF and standard chemotherapy dose without rhGM-CSF 1996
14 2-3 p. 401-
1 p.
artikel
70 Investigation for mediastinal disease in patients with apparently operable lung cancer 1996
14 2-3 p. 396-
1 p.
artikel
71 K-ras genotypes and prognosis in non-small-cell lung cancer 1996
14 2-3 p. 389-390
2 p.
artikel
72 Limited-stage small-cell lung cancer: Patient survival after combined chemotherapy and radiation therapy with and without treatment protocols 1996
14 2-3 p. 406-
1 p.
artikel
73 Loss of nm23 and Alu DNA in human lung cancer propagated in nude mice 1996
14 2-3 p. 381-382
2 p.
artikel
74 Lung Cancer Bergman, Bengt
1996
14 2-3 p. 373-374
2 p.
artikel
75 Lung cancer and ipsilateral pleural effusion 1996
14 2-3 p. 389-
1 p.
artikel
76 Lung cancer-induced blindness Thirkill, Charles E.
1996
14 2-3 p. 253-264
12 p.
artikel
77 Lung cancer risk in African-Americans in relation to a racespecific CYP1a1 polymorphism 1996
14 2-3 p. 377-
1 p.
artikel
78 Lymphoepithelioma-like carcinoma of the lung: Analysis of two cases for Epstein-Barr virus infection 1996
14 2-3 p. 378-
1 p.
artikel
79 Meat consumption and risk of lung cancer; a case-control study from Uruguay Deneo-Pellegrini, Hugo
1996
14 2-3 p. 195-205
11 p.
artikel
80 Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage 1996
14 2-3 p. 381-
1 p.
artikel
81 Mega-dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) for small cell lung cancer (SCLC) 1996
14 2-3 p. 400-
1 p.
artikel
82 Meta-analysis of studies of lung cancer among silicotics 1996
14 2-3 p. 380-
1 p.
artikel
83 Metastatic lung cancer initially presenting as Cushing's syndrome of pituitary origin. 25 year follow-up 1996
14 2-3 p. 392-393
2 p.
artikel
84 Mitogenic effect of serotonin in human small cell lung carcinoma cells via both 5-HT(1A) and 5-HT(1D) receptors 1996
14 2-3 p. 383-
1 p.
artikel
85 Mitomycin C and menadione for the treatment of lung cancer: A phase II trial 1996
14 2-3 p. 398-
1 p.
artikel
86 Modulation of sensitivity to mitomycin C and a dithiol analogue by tempol in non-small-cell lung cancer cell lines under hypoxia 1996
14 2-3 p. 398-
1 p.
artikel
87 Molecular and immunohistochemical study of class I growth factor receptors in squamous cell lung carcinomas 1996
14 2-3 p. 381-
1 p.
artikel
88 Molecular genetic tumor markers in the early diagnosis and screening of non-small-cell lung cancer 1996
14 2-3 p. 390-
1 p.
artikel
89 Monitoring lung cancer with tissue polypeptide antigen: An ancillary, profitable serum test to evaluate treatment response and posttreatment disease status 1996
14 2-3 p. 395-396
2 p.
artikel
90 Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patients Bretti, S.
1996
14 2-3 p. 353-360
8 p.
artikel
91 Multimodality therapy including surgical resection for limited small cell lung cancer 1996
14 2-3 p. 407-
1 p.
artikel
92 Multiplanar display of spiral CT data of the pulmonary hila in patients with lung cancer. Preliminary observations 1996
14 2-3 p. 393-
1 p.
artikel
93 Multiple chromosomal aberrations and 11p allelotyping in lung cancer cell lines 1996
14 2-3 p. 380-
1 p.
artikel
94 Mutant frequency at the hprt locus in human lymphocytes in a case-control study of lung cancer 1996
14 2-3 p. 389-
1 p.
artikel
95 Necrosis of the bronchus: Role of radiation 1996
14 2-3 p. 403-
1 p.
artikel
96 Neoadjuvant chemotherapy in non-small cell lung cancer for stages IIIa and IIIb 1996
14 2-3 p. 406-
1 p.
artikel
97 Neoadjuvant radio-chemotherapy in locally advanced non-small lung cancer. First results of a multicentric prospective study 1996
14 2-3 p. 406-407
2 p.
artikel
98 Ongoing randomised trials in Lung Cancer 1996
14 2-3 p. 369-372
4 p.
artikel
99 Outcome of patients with brain metastases after combined modality therapy in small cell lung cancer (SCLC): A retrospective study 1996
14 2-3 p. 407-
1 p.
artikel
100 Palliative radiation for stage 3 non-small cell lung cancer — A prospective study of two moderately high dose regimens 1996
14 2-3 p. 404-
1 p.
artikel
101 Peptide amidating activity in human bronchoalveolar lavage fluid Scott, Frank M.
1996
14 2-3 p. 239-251
13 p.
artikel
102 Pharmacokinetics and scintigraphy of indium-111-DTPA-MOC-31 in small-cell lung carcinoma 1996
14 2-3 p. 386-
1 p.
artikel
103 Phase II study of infusional cisplatin in combination with etoposide in the treatment of small cell lung cancer 1996
14 2-3 p. 400-
1 p.
artikel
104 Pituitary a denylate cyclase activating peptide receptors regulate the growth of non-small cell lung cancer cells 1996
14 2-3 p. 383-
1 p.
artikel
105 p53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survival 1996
14 2-3 p. 390-
1 p.
artikel
106 Post-treatment management options for patients with lung cancer 1996
14 2-3 p. 387-
1 p.
artikel
107 Potential role of environmental and domestic exposure to tremolite in pleural cancer in New Caledonia 1996
14 2-3 p. 379-
1 p.
artikel
108 Predictive value of urinary neopterin in patients with lung cancer 1996
14 2-3 p. 391-
1 p.
artikel
109 Preferential expression of the multidrug-resistance-associated protein (MRP) in adenocarcinoma of the lung 1996
14 2-3 p. 400-401
2 p.
artikel
110 Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer 1996
14 2-3 p. 402-403
2 p.
artikel
111 Primary lung cancer in Mexico city: a report of 1019 cases Medina, F.M.
1996
14 2-3 p. 185-193
9 p.
artikel
112 Primary lung cancer of the middle lobe. Is its prognosis poor? Miura, Hiroyuki
1996
14 2-3 p. 273-279
7 p.
artikel
113 Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer 1996
14 2-3 p. 388-
1 p.
artikel
114 Properties of classic protein kinase C in human small cell lung carcinoma NCI-H345 cells 1996
14 2-3 p. 380-
1 p.
artikel
115 Protein 1 (Clara cell protein) serum levels in lung cancer patients receiving chemotherapy 1996
14 2-3 p. 400-
1 p.
artikel
116 Pulmonary function changes in lung-cancer patients treated with radiation with or without carboplatin 1996
14 2-3 p. 388-389
2 p.
artikel
117 Pulmonary hypertrophic osteoarthropathy and clubbing of fingers in patients with lung cancer 1996
14 2-3 p. 391-
1 p.
artikel
118 Pulmonary myxoid leiomyosarcoma 1996
14 2-3 p. 384-
1 p.
artikel
119 Radiographic changes following radiotherapy in the patients with lung cancer 1996
14 2-3 p. 404-
1 p.
artikel
120 Radon and risk of cancer: Epidemiological studies after occupational and domestic exposure 1996
14 2-3 p. 379-
1 p.
artikel
121 Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer 1996
14 2-3 p. 387-
1 p.
artikel
122 Relations between chest CT and pathologic findings in pulmonary infarction associated with lung cancer 1996
14 2-3 p. 392-
1 p.
artikel
123 Report on 3rd Central European Lung Cancer Conference, Prague, 28–31 May 1995 Gregor, Anna
1996
14 2-3 p. 367-368
2 p.
artikel
124 Resection of stage III non-small cell lung cancer following induction therapy 1996
14 2-3 p. 404-405
2 p.
artikel
125 Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors 1996
14 2-3 p. 377-378
2 p.
artikel
126 Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population 1996
14 2-3 p. 379-380
2 p.
artikel
127 r-metHuG-CSF support to ifosfamide, cisplatin, etoposide chemotherapy in non-small cell lung cancer Gautier, Véronique
1996
14 2-3 p. 343-351
9 p.
artikel
128 Role of transesophageal echocardiography in the management of patients with bronchogenic carcinoma invading the left atrium 1996
14 2-3 p. 394-
1 p.
artikel
129 Selective suppression of cytokine secretion in patients with small-lung cancer 1996
14 2-3 p. 390-391
2 p.
artikel
130 Shared cytogenetic abnormalities in lung tumours and corresponding peripheral blood lymphocytes 1996
14 2-3 p. 382-
1 p.
artikel
131 Single agent Taxol, 3-hour infusion, in untreated advanced non-small-cell lung cancer 1996
14 2-3 p. 399-
1 p.
artikel
132 Splenic metastasis from lung cancer 1996
14 2-3 p. 387-
1 p.
artikel
133 Spontaneous remission of a cancer of the right lung, following left side pneumonectomy because of squamous cell lung cancer, four years ago 1996
14 2-3 p. 396-
1 p.
artikel
134 Stability of p53 tumor suppressor gene mutations during the process of metastasis and during chemotherapy Taniguchi, Yasuyuki
1996
14 2-3 p. 219-228
10 p.
artikel
135 Standard and variant CD44 isoforms are commonly expressed in lung cancer of the non-small cell type but not of the small cell type 1996
14 2-3 p. 384-
1 p.
artikel
136 Stent implantation in the palliative treatment of obstruction of the upper inflow veins in patients with bronchial carcinoma 1996
14 2-3 p. 397-
1 p.
artikel
137 Surgery for cure followed by chemotherapy in small cell carcinoma of the lung. For the ISC-Lung Cancer Study Group 1996
14 2-3 p. 407-
1 p.
artikel
138 Surgical treatment of primary lung cancer: A multivariate analysis of prognostic factors 1996
14 2-3 p. 397-
1 p.
artikel
139 Survival following radiotherapy for post-surgical locoregional recurrence of non-small cell lung cancer 1996
14 2-3 p. 404-
1 p.
artikel
140 Survival of patients with limited small cell lung cancer in whom complete remission was obtained (a non-randomised retrospective study of 124 consecutive patients) 1996
14 2-3 p. 408-
1 p.
artikel
141 Tea consumption and lung cancer risk: A case-control study in Okinawa, Japan 1996
14 2-3 p. 377-
1 p.
artikel
142 Technique and early results of percutaneous fine-needle brachytherapy for lung carcinoma 1996
14 2-3 p. 403-
1 p.
artikel
143 The curative treatment by radiotherapy alone of stage I nonsmall cell carcinoma of the lung 1996
14 2-3 p. 403-
1 p.
artikel
144 The diagnostic accuracy of a solitary pulmonary nodule, using thin-section high resolution CT: A solitary pulmonary nodule by HRCT 1996
14 2-3 p. 396-
1 p.
artikel
145 The expression of trophoblastic cell markers by lung carcinomas 1996
14 2-3 p. 385-
1 p.
artikel
146 The limits of chemotherapy dose intensification using Granulocyte Colony Stimulating Factor alone in extensive small cell lung cancer Trillet-Lenoir, V.
1996
14 2-3 p. 331-341
11 p.
artikel
147 The pharmacokinetic behaviour of hypoxoside taken orally by patients with lung cancer in a phase I trial 1996
14 2-3 p. 401-
1 p.
artikel
148 The presentation of primary bronchial adenocarcinoma and the evolution observed in a pneumology service over an 11 year period 1996
14 2-3 p. 395-
1 p.
artikel
149 The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer Kwa, H.B.
1996
14 2-3 p. 207-217
11 p.
artikel
150 Therapeutic options for regionally advanced non-small cell lung cancer Buccheri, Gianfranco
1996
14 2-3 p. 281-300
20 p.
artikel
151 The role of induction therapy and surgery for stage IIIA lung cancer 1996
14 2-3 p. 406-
1 p.
artikel
152 The role of radiotherapy as curative treatment in patients with stage III non-small cell lung cancer 1996
14 2-3 p. 404-
1 p.
artikel
153 The role of vinorelbine in the treatment of microcellular lung carcinoma 1996
14 2-3 p. 399-
1 p.
artikel
154 The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy 1996
14 2-3 p. 402-
1 p.
artikel
155 The usefulness of 99mTc-tetrofosmin in the diagnosis of lung tumors. A preliminary assessment 1996
14 2-3 p. 395-
1 p.
artikel
156 The value of tumor markers in the diagnosis, staging and prognosis of lung cancer 1996
14 2-3 p. 395-
1 p.
artikel
157 Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma 1996
14 2-3 p. 386-
1 p.
artikel
158 Transgenic mice bearing the polyomavirus large T antigen directed by 2.1 kb of the Keratin 19 promoter develop bronchiolar papillary tumors with progression to lung adenocarcinomas 1996
14 2-3 p. 377-
1 p.
artikel
159 Treatment of malignant obstruction of the superior vena cava with the self-expanding Wallstent 1996
14 2-3 p. 408-
1 p.
artikel
160 Treatment of multiple primary squamous cell carcinomas of the lung 1996
14 2-3 p. 396-397
2 p.
artikel
161 Treatment of pancoast tumors: Combined irradiation and radical resection 1996
14 2-3 p. 406-
1 p.
artikel
162 Treatment of unresectable lung cancer with brachytherapy 1996
14 2-3 p. 403-
1 p.
artikel
163 Tumor markers as prognostic factors in non-small-cell lung cancer 1996
14 2-3 p. 396-
1 p.
artikel
164 Tumour response evaluation during lung cancer chemotherapy 1996
14 2-3 p. 401-
1 p.
artikel
165 Value of photodynamic diagnosis in bronchology: Early detection of lung cancer possible? 1996
14 2-3 p. 391-
1 p.
artikel
                             165 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland